Expression of serotonin transporters by peripheral blood mononuclear cells of rhesus monkeys (Macaca mulatta)

Cellular Immunology

Volumn 248, Issue 2, 2007, Pages 69-76

  Yang, G B ^a   Qiu, C L ^a   Aye, P ^b   Shao, Y ^a   Lackner, A A ^b  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

Author keywords

Confocal microscopy; Flow cytometry; Peripheral blood mononuclear cells; Rhesus macaque; Serotonin transporter

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; MESSENGER RNA; RNA; SEROTONIN TRANSPORTER;

AMPLICON; ANIMAL CELL; ARTICLE; CONFOCAL MICROSCOPY; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSCRIPTION; MACACA; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; RNA TRANSLATION;

ANIMALS; FLOW CYTOMETRY; LEUKOCYTES, MONONUCLEAR; MACACA MULATTA; MICROSCOPY, CONFOCAL; RNA, MESSENGER; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

MACACA MULATTA;

EID: 37449029821     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2007.09.001     Document Type: Article

References (60)

1. Roszman T.L., and Brooks W.H. Neural modulation of immune function. J. Neuroimmunol. 10 (1985) 59-69
2. Sternberg E.M., Wedner H.J., Leung M.K., and Parker C.W. Effect of serotonin (5-HT) and other monoamines on murine macrophages: modulation of interferon-gamma induced phagocytosis. J. Immunol. 138 (1987) 4360-4365
3. Gershon M.D. Nerves, reflexes, and the enteric nervous system: pathogenesis of the irritable bowel syndrome. J. Clin. Gastroenterol. 39 (2005) S184-S193
4. Higley J.D., Suomi S.J., and Linnoila M. A nonhuman primate model of type II alcoholism? Part 2. Diminished social competence and excessive aggression correlates with low cerebrospinal fluid 5-hydroxyindoleacetic acid concentrations. Alcohol Clin. Exp. Res. 20 (1996) 643-650
5. Badawy A.A. Alcohol, aggression and serotonin: metabolic aspects. Alcohol Alcohol 33 (1998) 66-72
6. Joffe H., and Cohen L.S. Estrogen, serotonin, and mood disturbance: where is the therapeutic bridge?. Biol. Psychiatry 44 (1998) 798-811
7. Mayer L.E., and Walsh B.T. The use of selective serotonin reuptake inhibitors in eating disorders. J. Clin. Psychiatry 59 Suppl. 15 (1998) 28-34
8. Meltzer C.C., Smith G., DeKosky S.T., Pollock B.G., Mathis C.A., Moore R.Y., Kupfer D.J., and Reynolds III C.F. Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging role of functional imaging. Neuropsychopharmacology 18 (1998) 407-430
9. Urbina M., Pineda S., Pinango L., Carreira I., and Lima L. [3H]Paroxetine binding to human peripheral lymphocyte membranes of patients with major depression before and after treatment with fluoxetine. Int. J. Immunopharmacol. 21 (1999) 631-646
10. Marazziti D., Baroni S., Masala I., Giannaccini G., Mungai F., Di Nasso E., and Cassano G.B. Decreased lymphocyte 3H-paroxetine binding in obsessive-compulsive disorder. Neuropsychobiology 47 (2003) 128-130
11. G.B. Yang, Progress in the studies on immunomodulatory effects of 5-HT, Sheng Li Ke Xue Jin Zhan 28 (1997), 349-351.
12. Mossner R., and Lesch K.P. Role of serotonin in the immune system and in neuroimmune interactions. Brain Behav. Immun. 12 (1998) 249-271
13. Abdouh M., Albert P.R., Drobetsky E., Filep J.G., and Kouassi E. 5-HT1A-mediated promotion of mitogen-activated T and B cell survival and proliferation is associated with increased translocation of NF-kappaB to the nucleus. Brain Behav. Immun. 18 (2004) 24-34
14. Csaba G., Karabelyos C., Inczefi-Gonda A., and Pallinger E. Three-generation investigation on serotonin content in rat immune cells long after beta-endorphin exposure in late pregnancy. Horm. Metab. Res. 37 (2005) 172-177
15. Vega Lde L., Munoz E., Calzado M.A., Lieb K., Candelario-Jalil E., Gschaidmeir H., Farber L., Mueller W., Stratz T., and Fiebich B.L. The 5-HT3 receptor antagonist tropisetron inhibits T cell activation by targeting the calcineurin pathway. Biochem. Pharmacol. 70 (2005) 369-380
16. Geeraerts B., van Oudenhove L., and Tack J. Serotonin transporter gene polymorphisms in irritable bowel syndrome. Neurogastroenterol. Motil. 18 (2006) 957-959
17. Katoh N., Soga F., Nara T., Tamagawa-Mineoka R., Nin M., Kotani H., Masuda K., and Kishimoto S. Effect of serotonin on the differentiation of human monocytes into dendritic cells. Clin. Exp. Immunol. 146 (2006) 354-361
18. O'Connell P.J., Wang X., Leon-Ponte M., Griffiths C., Pingle S.C., and Ahern G.P. A novel form of immune signaling revealed by transmission of the inflammatory mediator serotonin between dendritic cells and T cells. Blood 107 (2006) 1010-1017
19. Goadsby P.J. Serotonin receptor ligands: treatments of acute migraine and cluster headache. Handb. Exp. Pharmacol. (2007) 129-143
20. Ramamoorthy S., Bauman A.L., Moore K.R., Han H., Yang-Feng T., Chang A.S., Ganapathy V., and Blakely R.D. Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc. Natl. Acad. Sci. USA 90 (1993) 2542-2546
21. Lesch K.P., Wolozin B.L., Estler H.C., Murphy D.L., and Riederer P. Isolation of a cDNA encoding the human brain serotonin transporter. J. Neural. Transm. Gen. Sect. 91 (1993) 67-72
22. Corey J.L., Quick M.W., Davidson N., Lester H.A., and Guastella J. A cocaine-sensitive Drosophila serotonin transporter: cloning, expression, and electrophysiological characterization. Proc. Natl. Acad. Sci. USA 91 (1994) 1188-1192
23. Chang A.S., Chang S.M., Starnes D.M., Schroeter S., Bauman A.L., and Blakely R.D. Cloning and expression of the mouse serotonin transporter. Brain Res. Mol. Brain Res. 43 (1996) 185-192
24. Miller G.M., Yatin S.M., De La Garza II R., Goulet M., and Madras B.K. Cloning of dopamine, norepinephrine and serotonin transporters from monkey brain: relevance to cocaine sensitivity. Brain Res. Mol. Brain Res. 87 (2001) 124-143
25. Desrosiers R.C., Wyand M.S., Kodama T., Ringler D.J., Arthur L.O., Sehgal P.K., Letvin N.L., King N.W., and Daniel M.D. Vaccine protection against simian immunodeficiency virus infection. Proc. Natl. Acad. Sci. USA 86 (1989) 6353-6357
26. Kuhar M.J., McGirr K.M., Hunter R.G., Lambert P.D., Garrett B.E., and Carroll F.I. Studies of selected phenyltropanes at monoamine transporters. Drug Alcohol. Depend. 56 (1999) 9-15
27. Champoux M., Bennett A., Shannon C., Higley J.D., Lesch K.P., and Suomi S.J. Serotonin transporter gene polymorphism, differential early rearing, and behavior in rhesus monkey neonates. Mol. Psychiatry 7 (2002) 1058-1063
28. Barr C.S., Newman T.K., Becker M.L., Champoux M., Lesch K.P., Suomi S.J., Goldman D., and Higley J.D. Serotonin transporter gene variation is associated with alcohol sensitivity in rhesus macaques exposed to early-life stress. Alcohol. Clin. Exp. Res. 27 (2003) 812-817
29. Chuang R.Y., Suzuki S., Chuang T.K., Miyagi T., Chuang L.F., and Doi R.H. Opioids and the progression of simian AIDS. Front Biosci. 10 (2005) 1666-1677
30. Poonia B., Nelson S., Bagby G.J., and Veazey R.S. Intestinal lymphocyte subsets and turnover are affected by chronic alcohol consumption: implications for SIV/HIV infection. J. Acquir. Immune Defic. Syndr. 41 (2006) 537-547
31. Pecins-Thompson M., Brown N.A., and Bethea C.L. Regulation of serotonin re-uptake transporter mRNA expression by ovarian steroids in rhesus macaques. Brain Res. Mol. Brain Res. 53 (1998) 120-129
32. Zeng Z., Chen T.B., Miller P.J., Dean D., Tang Y.S., Sur C., and Williams Jr. D.L. The serotonin transporter in rhesus monkey brain: comparison of DASB and citalopram binding sites. Nucl. Med. Biol. 33 (2006) 555-563
33. Schutzer W.E., and Bethea C.L. Lack of ovarian steroid hormone regulation of norepinephrine transporter mRNA expression in the non-human primate locus coeruleus. Psychoneuroendocrinology 22 (1997) 325-336
34. Ichise M., Vines D.C., Gura T., Anderson G.M., Suomi S.J., Higley J.D., and Innis R.B. Effects of early life stress on [11C]DASB positron emission tomography imaging of serotonin transporters in adolescent peer- and mother-reared rhesus monkeys. J. Neurosci. 26 (2006) 4638-4643
35. Howell L.L., Carroll F.I., Votaw J.R., Goodman M.M., and Kimmel H.L. Effects of combined dopamine and serotonin transporter inhibitors on cocaine self-administration in rhesus monkeys. J. Pharmacol. Exp. Ther. 320 (2007) 757-765
36. Yang G.B., and Lackner A.A. Proximity between 5-HT secreting enteroendocrine cells and lymphocytes in the gut mucosa of rhesus macaques (Macaca mulatta) is suggestive of a role for enterochromaffin cell 5-HT in mucosal immunity. J. Neuroimmunol. 146 (2004) 46-49
37. Yang G.B., Qiu C.L., Zhao H., Liu Q., and Shao Y. Expression of mRNA for multiple serotonin (5-HT) receptor types/subtypes by the peripheral blood mononuclear cells of rhesus macaques. J. Neuroimmunol. 178 (2006) 24-29
38. Nattie E.E., Li A., Richerson G., and Lappi D.A. Medullary serotonergic neurones and adjacent neurones that express neurokinin-1 receptors are both involved in chemoreception in vivo. J. Physiol. 556 (2004) 235-253
39. Muller N., and Schwarz M.J. Neuroimmune-endocrine crosstalk in schizophrenia and mood disorders. Expert. Rev. Neurother. 6 (2006) 1017-1038
40. Faraj B.A., Olkowski Z.L., and Jackson R.T. Expression of a high-affinity serotonin transporter in human lymphocytes. Int. J. Immunopharmacol. 16 (1994) 561-567
41. Hernandez E., Lastra S., Urbina M., Carreira I., and Lima L. Serotonin, 5-hydroxyindoleacetic acid and serotonin transporter in blood peripheral lymphocytes of patients with generalized anxiety disorder. Int. Immunopharmacol. 2 (2002) 893-900
42. Lima L., Mata S., and Urbina M. Allelic isoforms and decrease in serotonin transporter mRNA in lymphocytes of patients with major depression. Neuroimmunomodulation 12 (2005) 299-306
43. Barkan T., Gurwitz D., Levy G., Weizman A., and Rehavi M. Biochemical and pharmacological characterization of the serotonin transporter in human peripheral blood lymphocytes. Eur. Neuropsychopharmacol. 14 (2004) 237-243
44. Barkan T., Hermesh H., Marom S., Gurwitz D., Weizman A., and Rehavi M. Serotonin uptake to lymphocytes of patients with social phobia compared to normal individuals. Eur. Neuropsychopharmacol. 16 (2006) 19-23
45. Marazziti D., Dell'Osso B., Baroni S., Betti L., Catena M., Giannaccini G., Lucacchini A., and Cassano G.B. Common alterations in the serotonin transporter in platelets and lymphocytes of psychotic patients. Pharmacopsychiatry 39 (2006) 35-38
46. Ferriere F., Khan N.A., Meyniel J.P., and Deschaux P. Characterisation of serotonin transport mechanisms in rainbow trout peripheral blood lymphocytes: role in PHA-induced lymphoproliferation. Dev. Comp. Immunol. 23 (1999) 37-50
47. Pellegrino T.C., and Bayer B.M. Specific serotonin reuptake inhibitor-induced decreases in lymphocyte activity require endogenous serotonin release. Neuroimmunomodulation 8 (2000) 179-187
48. Serafeim A., Holder M.J., Grafton G., Chamba A., Drayson M.T., Luong Q.T., Bunce C.M., Gregory C.D., Barnes N.M., and Gordon J. Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cells. Blood 101 (2003) 3212-3219
49. Meredith E.J., Chamba A., Holder M.J., Barnes N.M., and Gordon J. Close encounters of the monoamine kind: immune cells betray their nervous disposition. Immunology 115 (2005) 289-295
50. Hellstrand K., Czerkinsky C., Ricksten A., Jansson B., Asea A., Kylefjord H., and Hermodsson S. Role of serotonin in the regulation of interferon-gamma production by human natural killer cells. J. Interferon Res. 13 (1993) 33-38
51. Young M.R., and Matthews J.P. Serotonin regulation of T-cell subpopulations and of macrophage accessory function. Immunology 84 (1995) 148-152
52. Mossner R., Daniel S., Schmitt A., Albert D., and Lesch K.P. Modulation of serotonin transporter function by interleukin-4. Life Sci. 68 (2001) 873-880
53. Gordon J., and Barnes N.M. Lymphocytes transport serotonin and dopamine: agony or ecstasy?. Trends Immunol. 24 (2003) 438-443
54. Launay J.M., Copel L., Callebert J., Corvaia N., Bricaire F., Laplanche J.L., Saal F., and Peries J. Serotonin and human immunodeficiency viruses. Nouv. Rev. Fr. Hematol. 31 (1989) 159-161
55. Dursun S.M., and Handley S.L. Serotonin, eating disorders, and HIV infection. Br. J. Psychiatry 160 (1992) 866-867
56. Elliott A.J., and Roy-Byrne P.P. Major depressive disorder and HIV-1 infection: a review of treatment trials. Semin. Clin. Neuropsychiatry 3 (1998) 137-150
57. DeSilva K.E., Le Flore D.B., Marston B.J., and Rimland D. Serotonin syndrome in HIV-infected individuals receiving antiretroviral therapy and fluoxetine. Aids 15 (2001) 1281-1285
58. Caballero J., and Nahata M.C. Use of selective serotonin-reuptake inhibitors in the treatment of depression in adults with HIV. Ann. Pharmacother. 39 (2005) 141-145
59. Pieper A.A., and Treisman G.J. Drug treatment of depression in HIV-positive patients: safety considerations. Drug Saf. 28 (2005) 753-762
60. Longatti P., Perin A., Comai S., Bertazzo A., Rizzo V., Costa C.V., and Allegri G. A study of tryptophan metabolism via serotonin in ventricular cerebrospinal fluid in HIV-1 infection using a neuroendoscopic technique. Curr. HIV Res. 5 (2007) 267-272